The molecular epidemiology of equine influenza in Ireland from 2007-2010 and its international significance.
- Journal Article
- Research Support
- Non-U.S. Gov't
Summary
This research investigated the genetic variation of equine influenza viruses in Ireland between 2007-2010, providing valuable information for local and global vaccine creation and prevention strategies.
Objective and Methodology
The primary goal of the study was to summarize the genetic analysis of equine influenza (EI) viruses found in Ireland from June 2007 to January 2010. The research aimed to discover how these viruses evolve, which influences their disease causing potential.
Results
The researchers clarified important aspects of the genetic makeup and evolution of the EI viruses circulating in Ireland within the stated period.
- All viruses studied were categorized under the Florida sublineage of the American lineage, signifying that they shared common evolutionary ancestors.
- Up until 2009, Clade 2 viruses were predominant. These viruses were identical to the A/eq/Richmond/1/07 virus, the formal sample for Clade 2 at that time.
- The first Clade 1 virus was identified in November 2009, after which Clade 1 became responsible for all subsequent outbreaks.
- The Irish Clade 1 viruses differed from the Clade 1 viruses responsible for the EI outbreaks in Japan and Australia in 2007, denoting regional variations.
- No virus of the Eurasian lineage was found during this surveillance period.
Significance and Conclusions
The ESP (Expert Surveillance Panel) utilizes this sort of crucial genetic surveillance data to create annual recommendations on updates needed for EI vaccines.
- Based on the results of this research, the ESP recommended in 2010 that the vaccines should not include a H7N7 virus or a H3N8 virus of the Eurasian lineage.
- Instead, they suggested vaccines should contain both a Clade 1 and Clade 2 virus from the Florida sublineage. The study fully supported these recommendations and proved their epidemiological relevance.
- The information provided also forms a solid basis for studying the causes and sources of future EI epidemics and outbreaks on both a national and international scale.
Cite This Article
Publication
Researcher Affiliations
- Virology Unit, The Irish Equine Centre, Johnstown, Naas, Co. Kildare, Ireland.
MeSH Terms
- Animals
- Hemagglutinins / genetics
- Horse Diseases / epidemiology
- Horse Diseases / prevention & control
- Horse Diseases / virology
- Horses
- Influenza A virus / classification
- Influenza A virus / genetics
- Influenza Vaccines / administration & dosage
- Influenza Vaccines / immunology
- Internationality
- Ireland / epidemiology
- Molecular Epidemiology
- Orthomyxoviridae Infections / epidemiology
- Orthomyxoviridae Infections / prevention & control
- Orthomyxoviridae Infections / veterinary
- Phylogeny
- Time Factors
Citations
This article has been cited 20 times.- Pellegrini F, Buonavoglia A, Omar AH, Diakoudi G, Lucente MS, Odigie AE, Sposato A, Augelli R, Camero M, Decaro N, Elia G, Bányai K, Martella V, Lanave G. A Cold Case of Equine Influenza Disentangled with Nanopore Sequencing. Animals (Basel) 2023 Mar 24;13(7).
- Olguin-Perglione C, Barrandeguy ME. An Overview of Equine Influenza in South America. Viruses 2021 May 12;13(5).
- Entenfellner J, Gahan J, Garvey M, Walsh C, Venner M, Cullinane A. Response of Sport Horses to Different Formulations of Equine Influenza Vaccine. Vaccines (Basel) 2020 Jul 10;8(3).
- Gahan J, Garvey M, Asmah Abd Samad R, Cullinane A. Whole Genome Sequencing of the First H3N8 Equine Influenza Virus Identified in Malaysia. Pathogens 2019 May 10;8(2).
- Miño S, Mojsiejczuk L, Guo W, Zhang H, Qi T, Du C, Zhang X, Wang J, Campos R, Wang X. Equine Influenza Virus in Asia: Phylogeographic Pattern and Molecular Features Reveal Circulation of an Autochthonous Lineage. J Virol 2019 Jul 1;93(13).
- Brister H, Barnum SM, Reedy S, Chambers TM, Pusterla N. Validation of two multiplex real-time PCR assays based on single nucleotide polymorphisms of the HA1 gene of equine influenza A virus in order to differentiate between clade 1 and clade 2 Florida sublineage isolates. J Vet Diagn Invest 2019 Jan;31(1):137-141.
- Singh RK, Dhama K, Karthik K, Khandia R, Munjal A, Khurana SK, Chakraborty S, Malik YS, Virmani N, Singh R, Tripathi BN, Munir M, van der Kolk JH. A Comprehensive Review on Equine Influenza Virus: Etiology, Epidemiology, Pathobiology, Advances in Developing Diagnostics, Vaccines, and Control Strategies. Front Microbiol 2018;9:1941.
- Gildea S, Garvey M, Lyons P, Lyons R, Gahan J, Walsh C, Cullinane A. Multifocal Equine Influenza Outbreak with Vaccination Breakdown in Thoroughbred Racehorses. Pathogens 2018 Apr 17;7(2).
- Favaro PF, Fernandes WR, Reischak D, Brandão PE, Silva SOS, Richtzenhain LJ. Evolution of equine influenza viruses (H3N8) during a Brazilian outbreak, 2015. Braz J Microbiol 2018 Apr-Jun;49(2):336-346.
- Gahan J, Garvey M, Gildea S, Gür E, Kagankaya A, Cullinane A. Whole-genome sequencing and antigenic analysis of the first equine influenza virus identified in Turkey. Influenza Other Respir Viruses 2018 May;12(3):374-382.
- Rash A, Morton R, Woodward A, Maes O, McCauley J, Bryant N, Elton D. Evolution and Divergence of H3N8 Equine Influenza Viruses Circulating in the United Kingdom from 2013 to 2015. Pathogens 2017 Feb 8;6(1).
- Olguin Perglione C, Golemba MD, Torres C, Barrandeguy M. Molecular Epidemiology and Spatio-Temporal Dynamics of the H3N8 Equine Influenza Virus in South America. Pathogens 2016 Oct 16;5(4).
- Meseko CA, Ehizibolo DO, Nwokike EC, Wungak YS. Serological evidence of equine influenza virus in horse stables in Kaduna, Nigeria. J Equine Sci 2016;27(3):99-105.
- Alves Beuttemmüller E, Woodward A, Rash A, Dos Santos Ferraz LE, Fernandes Alfieri A, Alfieri AA, Elton D. Characterisation of the epidemic strain of H3N8 equine influenza virus responsible for outbreaks in South America in 2012. Virol J 2016 Mar 19;13:45.
- Perglione CO, Gildea S, Rimondi A, Miño S, Vissani A, Carossino M, Cullinane A, Barrandeguy M. Epidemiological and virological findings during multiple outbreaks of equine influenza in South America in 2012. Influenza Other Respir Viruses 2016 Jan;10(1):37-46.
- Kim EJ, Kim BH, Yang S, Choi EJ, Shin YJ, Song JY, Shin YK. Antibody responses after vaccination against equine influenza in the Republic of Korea in 2013. J Vet Med Sci 2015 Nov;77(11):1517-21.
- Pusterla N, Kass PH, Mapes S, Wademan C, Akana N, Barnett C, MacKenzie C, Vaala W. Voluntary surveillance program for equine influenza virus in the United States from 2010 to 2013. J Vet Intern Med 2015 Jan;29(1):417-22.
- Pouwels HG, Van de Zande SM, Horspool LJ, Hoeijmakers MJ. Efficacy of a non-updated, Matrix-C-based equine influenza subunit-tetanus vaccine following Florida sublineage clade 2 challenge. Vet Rec 2014 Jun 21;174(25):633.
- Gildea S, Fitzpatrick DA, Cullinane A. Epidemiological and virological investigations of equine influenza outbreaks in Ireland (2010-2012). Influenza Other Respir Viruses 2013 Dec;7 Suppl 4(Suppl 4):61-72.
- Kumar R, Bera BC, Anand T, Pavulraj S, Kurian Mathew M, Gupta RP, Tripathi BN, Virmani N. Evaluation of immunogenicity and protective efficacy of bacteriophage conjugated haemagglutinin based subunit vaccine against equine influenza virus in a murine model. Vet Res Commun 2024 Jun;48(3):1707-1726.